These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 15619026

  • 1. The rising tide of end-stage renal disease: what can be done?
    Glassock RJ.
    Clin Exp Nephrol; 2004 Dec; 8(4):291-6. PubMed ID: 15619026
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing the development of end-stage renal disease.
    Iseki K.
    Clin Exp Nephrol; 2005 Mar; 9(1):5-14. PubMed ID: 15830267
    [Abstract] [Full Text] [Related]

  • 3. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP, ESRD Incidence Study Group.
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [Abstract] [Full Text] [Related]

  • 4. Risk factors and prevention of end stage renal disease in uruguay.
    Mazzuchi N, Schwedt E, Solá L, González C, Ferreiro A.
    Ren Fail; 2006 Oct; 28(8):617-25. PubMed ID: 17162418
    [Abstract] [Full Text] [Related]

  • 5. Early diagnosis of CKD and its prevention.
    Amaresan MS, Geetha R.
    J Assoc Physicians India; 2008 Jan; 56():41-6. PubMed ID: 18472500
    [Abstract] [Full Text] [Related]

  • 6. The drumbeat of renal failure: symbiosis of prevention and renal replacement therapy.
    Dirks JH.
    Blood Purif; 2004 Jan; 22(1):6-8. PubMed ID: 14732805
    [Abstract] [Full Text] [Related]

  • 7. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ESRD Incidence Study GroupDepartment of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand. margaret.mccredie@stonebow.otago.ac.nz, Stewart JH, McCredie MR, Williams SM.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W.
    Ethn Dis; 2006 Aug; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [Abstract] [Full Text] [Related]

  • 10. Epidemic of chronic kidney disease in India -what can be done?
    Prabahar MR, Chandrasekaran V, Soundararajan P.
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):847-53. PubMed ID: 18711313
    [Abstract] [Full Text] [Related]

  • 11. End stage kidney disease: increasing incidence in Virginia.
    Moore MA.
    Va Med Q; 1993 Sep; 120(2):99-103. PubMed ID: 8481420
    [Abstract] [Full Text] [Related]

  • 12. Obesity and kidney disease: a big dilemma.
    Kramer H, Luke A.
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):237-41. PubMed ID: 17420667
    [Abstract] [Full Text] [Related]

  • 13. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.
    Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ, International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004.
    Kidney Int Suppl; 2005 Sep; (98):S1-6. PubMed ID: 16108963
    [Abstract] [Full Text] [Related]

  • 14. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI, Vikse BE.
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [Abstract] [Full Text] [Related]

  • 15. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ESRD Incidence Study GroupDepartment of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand. margaret.mccredie@stonebow.otago.ac.nz, Stewart JH, McCredie MR, Williams SM.
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [Abstract] [Full Text] [Related]

  • 16. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W, Suhardjono A.
    Ethn Dis; 2009 Dec; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [Abstract] [Full Text] [Related]

  • 17. [Diabetic renal disease: the World Kidney Day in Chile].
    Ardiles L, Mezzano S.
    Rev Med Chil; 2010 Apr; 138(4):397-400. PubMed ID: 20668785
    [Abstract] [Full Text] [Related]

  • 18. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO, Ayodele OE.
    Ethn Dis; 2005 Apr; 15(3):418-23. PubMed ID: 16108301
    [Abstract] [Full Text] [Related]

  • 19. Glomerulonephritis and managing the risks of chronic renal disease.
    Singh GR.
    Pediatr Clin North Am; 2009 Dec; 56(6):1363-82. PubMed ID: 19962026
    [Abstract] [Full Text] [Related]

  • 20. Trends of incident dialysis patients in Tunisia between 1992 and 2001.
    Counil E, Cherni N, Kharrat M, Achour A, Trimech H.
    Am J Kidney Dis; 2008 Mar; 51(3):463-70. PubMed ID: 18295062
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.